Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
IGXT | OTC Markets | USD | Delayed | |
IGX | Toronto | CAD | Delayed | |
IGX | CBOE Canada | CAD | Real-time | |
0IL | Frankfurt | EUR | Delayed |
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer and Parkinsons; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also develops INT0039/2013 for pain; and INT0053/2020 for the treatment of resistant depression. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
Name | Age | Since | Title |
---|---|---|---|
Horst G. Zerbe | 76 | 2006 | Chairman & Chairman of Scientific Advisory Board |
Sahil V. Kirpekar | 38 | 2023 | Director |
Ryan Barrett | - | 2023 | Director |
Bernd J. Melchers | 73 | 2009 | Independent Director |
Barry D. Greenberg | - | 2016 | Member of Scientific Advisory Board |
Ludwig Aigner | - | 2016 | Member of Scientific Advisory Board |
Mark H. Nawacki | 55 | 2016 | Independent Vice Chairman |
Clemens Mayr | 55 | 2015 | Director |
Nadine Paiement | 47 | 2005 | Vice-Chair of Scientific Advisory Board and VP of Research & Development - IntelGenx Corp |
Serge Gauthier | - | - | Member of Scientific Advisory Board |
Monika Trzcinska | 57 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review